Insider holders · CIK 0001631650
Aimmune Therapeutics, Inc. · AIMT
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Nestle Health Science US Holdings, Inc.10% Owner | — | 7,552,084 | 7,552,084 | Nov 23, 2016 · 4:49 pm EST | Form 3 |
| NIMCO US, Inc.10% Owner | — | 7,552,084 | 7,552,084 | Nov 23, 2016 · 4:49 pm EST | Form 3 |
| NESTLE SA10% Owner | — | 7,552,084 | 7,552,084 | Nov 23, 2016 · 4:49 pm EST | Form 3 |
| Patrick G EnrightDirector | 26,619 | 6,013,134 | 6,039,753 | May 24, 2018 · 5:09 pm EDT | Form 4 |
| Bakker Juliet Tammenoms10% Owner | 16,651 | 6,013,134 | 6,029,785 | Feb 26, 2018 · 4:25 pm EST | Form 4 |
| Longitude Capital Partners II, LLC10% Owner | 7,276 | 6,013,134 | 6,020,410 | Dec 1, 2016 · 9:50 pm EST | Form 4 |
| Longitude Venture Partners II, L.P.10% Owner | 7,276 | 6,013,134 | 6,020,410 | Dec 1, 2016 · 9:50 pm EST | Form 4 |
| Foresite Capital Fund III, L.P.10% Owner | — | 935,020 | 935,020 | Aug 19, 2016 · 1:55 pm EDT | Form 3 |
| Foresite Capital Management III, LLC10% Owner | — | 935,020 | 935,020 | Aug 19, 2016 · 1:55 pm EDT | Form 3 |
| Foresite Capital Fund II, L.P.10% Owner | — | 935,020 | 935,020 | Aug 19, 2016 · 1:55 pm EDT | Form 3 |
| Foresite Capital Management II, LLC10% Owner | — | 935,020 | 935,020 | Aug 19, 2016 · 1:55 pm EDT | Form 3 |
| James B. Tananbaum10% Owner | — | 935,020 | 935,020 | Aug 19, 2016 · 1:55 pm EDT | Form 3 |
| Howard V. RaffChief Operating Officer | — | 428,575 | 428,575 | Aug 5, 2015 · 6:41 pm EDT | Form 3 |
| Stephen George DillyPresident and CEO | 315,308 | 41,075 | 356,383 | Jun 13, 2018 · 4:06 pm EDT | Form 4 |
| Robert Myles ElfontChief Medical Officer | 299,002 | — | 299,002 | Feb 26, 2016 · 7:35 pm EST | Form 4 |
| Kathryn E FalbergDirector | 128,644 | — | 128,644 | May 24, 2018 · 5:06 pm EDT | Form 4 |
| Jayson Donald Alexander DallasPresident and CEO | 98,650 | — | 98,650 | Feb 26, 2019 · 4:05 pm EST | Form 4 |
| Douglas T. SheehySee Remarks | 45,668 | — | 45,668 | Feb 26, 2019 · 4:06 pm EST | Form 4 |
| Mark T IwickiDirector | 33,125 | — | 33,125 | May 24, 2018 · 5:06 pm EDT | Form 4 |
| Eric BjerkholtChief Financial Officer | 32,857 | — | 32,857 | Feb 26, 2019 · 4:06 pm EST | Form 4 |
| Daniel C Adelman M.D.Chief Medical Officer | 21,250 | — | 21,250 | Feb 26, 2019 · 4:06 pm EST | Form 4 |
| Warren L. DeSouzaChief Financial Officer | 20,681 | — | 20,681 | Apr 5, 2017 · 4:05 pm EDT | Form 4 |
| Mark McDadeDirector | 20,410 | — | 20,410 | May 24, 2018 · 5:05 pm EDT | Form 4 |
| Mary M. RozenmanSee Remarks | 14,504 | — | 14,504 | Feb 26, 2019 · 4:06 pm EST | Form 4 |
| Jeffrey H KnappChief Operating Officer | 12,151 | — | 12,151 | Mar 6, 2018 · 8:42 pm EST | Form 4 |
| Andrew OxtobyChief Commercial Officer | 12,000 | — | 12,000 | Jan 24, 2019 · 4:06 pm EST | Form 4 |
| Susan E. BarrowcliffeGeneral Manager, Europe | 9,375 | — | 9,375 | Nov 21, 2018 · 4:05 pm EST | Form 4 |
| Stacey Denenberg SeltzerDirector | 3,779 | — | 3,779 | May 24, 2018 · 5:09 pm EDT | Form 4 |
| Gregory BeharDirector | 3,750 | — | 3,750 | May 24, 2018 · 5:08 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.